Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg

@article{Disanto2009EffectOF,
  title={Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg},
  author={Anthony R. Disanto and Gil Golden},
  journal={Clinical Drug Investigation},
  year={2009},
  volume={29},
  pages={539-549}
}
AbstractBackground and objective: Food has reportedly not affected the systemic bioavailability of the atypical antipsychotic drug clozapine. However, searches of the medical literature could find no studies to support this food claim for any formulation of clozapine. The purpose of the current study was to assess the effect of food on the bioavailability and pharmacokinetics of clozapine orally disintegrating tablet (ODT) following single 12.5 mg doses in the healthy subjects in fasted and fed… 

Evaluation of Bioequivalence Between Clozapine Suspension and Tablet Formulations

The tablet and suspension formulations are bioequivalent, with similar safety profiles, under fed and fasted conditions, and safety/tolerability profiles were similar between the two formulations.

Alternative Routes of Administration of Clozapine

The administration of clozapine (suspension or crushed tablets) via enteral feeding tubes (predominantly nasogastric) has been reported both in medically unwell patients and in patients refusing clozAPine, and is likely to be superseded by intramuscular clozal administration.

Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.

  • Z. IsmailA. Wessels R. Bies
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2012
These findings have particular clinical relevance for the dosing and safety monitoring of clozapine in older adults, highlighting a need for increased vigilance.

Mechanistic studies and modeling of effects of ingested lipids on oral drug absorption

The study included experimental characterization and computational modelling of kinetics of parallel processes occurring in the GI tract after lipid ingestion – namely, compound dissolution, lipid digestion, compound partitioning into colloidal phases, absorption and a mechanistic and kinetic model of intestinal absorption in the presence of ingested lipids.

Effect of Ingested Lipids on Drug Dissolution and Release with Concurrent Digestion: A Modeling Approach

This model, once incorporated with a pharmacokinetic model considering processes of drug absorption and drug lymphatic transport in the presence of lipids, could be highly useful for quantitative prediction of impact oflipids on bioavailability of drugs.

Clinically Significant Interactions with Antipsychotics

Second-generation antipsychotics (SGAs) have become the mainstay of treatment for patients with schizophrenia and bipolar disorder. The antipsychotic drugs are often prescribed with other medications

Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation

  • S. FirminP. Gandia H. Boudra
  • Biology, Chemistry
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
  • 2010
YCW could be used to protect monogastric animals against exposure to low dietary levels of selected mycotoxins and is in agreement with the reported in vitro binding ability for these toxins.

The significance of sampling time in therapeutic drug monitoring of clozapine

Therapeutic drug monitoring (TDM) of clozapine is standardized to 12‐h postdose samplings. In clinical settings, sampling time often deviates from this time point, although the importance of the

Food-associated stimuli enhance barrier properties of mucus

The motivation for studying these phenomena includes understanding how drug delivery and microbe transport through mucus may change upon food exposure, and how these effects may be exploited to enable more efficient drug delivery or block pathogen transport.

Efficacité de détoxication de l'aflatoxine B1 et de l'ochratoxine A par un adsorbant organique : Evaluation par la balance d'excrétion et les paramètres toxicocinétiques chez le rat et la brebis laitière

L’aflatoxine B1 (AFB1) and l’ochratoxine A (OTA) sont des mycotoxines pouvant contaminer une large variete de denrees alimentaires, yn â’n ô’r conditions experimentales utilisees.

References

SHOWING 1-10 OF 16 REFERENCES

Bioequivalence of Clozapine Orally Disintegrating 100-mg Tablets Compared with Clozapine Solid Oral 100-mg Tablets after Multiple Doses in Patients with Schizophrenia

FazaClo® produced pharmacokinetic profiles almost identical to those of Clozaril®, which should provide clinicians with reassurance that patients with schizophrenia will achieve plasma drug concentrations similar to those produced by the same daily dose of Clazaril®, and that no cross-titration is necessary when switching from one of these clozapine formulations to the other.

Effect of caffeine on clozapine pharmacokinetics in healthy volunteers.

It is suggested that caffeine in daily doses of 400-1000 mg inhibits the metabolism of clozapine to an extent that might be clinically significant in certain individuals.

Absence of interaction between erythromycin and a single dose of clozapine

It is demonstrated that erythromycin at a clinically relevant dosage does not inhibit the metabolism of clozapine, and CYP3A4 seems to be of minor importance in the disposition of clazapine in humans at least when clozAPine is taken at a low single dose.

Pharmacokinetics and Pharmacodynamics of Clozapine

Careful patient selection and monitoring are required when clozapine therapy is used in patients with schizophrenia because the drug does possess significant binding affinity for different dopamine receptors, with recent evidence supporting binding to the D4 receptor subtype.

Examining Concentration-Dependent Toxicity of Clozapine: Role of Therapeutic Drug Monitoring

The authors present four cases illustrating the issues involved and how TMD can be used to improve clinical care of patients being treated with clozapine, both in terms of improving efficacy and minimizing potential toxicity.

Will Routine Therapeutic Drug Monitoring Have a Place in Clozapine Therapy?

It is concluded that therapeutic drug monitoring can play a useful role in the clinical management of patients treated with clozapine and that long term monitoring would, in this view, not be necessary.

Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age

A considerable variation of clozapine plasma levels at a given dose depending on a number of factors should be taken into consideration for efficient therapy with the lowest possible dose.

Clozapine: an atypical antipsychotic agent.

Double-blind comparative studies have shown clozapine to be superior to haloperidol, chlorpromazine, and placebo in treating the symptoms of schizophrenia, as measured with validated psychiatric rating scales.

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Clozapine therapy, performed in conjunction with close haematological monitoring, is indicated for the management of severe and chronic schizophrenia refractory to classic antipsychotic therapy, and in those unable to tolerate such therapy.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

For patients with schizophrenia who prospectively failed to improve with an atypical antipsychotic, clozapine was more effective than switching to another newer atypicals antipsychotics.